| Literature DB >> 36249259 |
Huiling Guo1,2, Zoe Jane-Lara Hildon2,3, Angela Chow1,2,4.
Abstract
Introduction: Shared decision-making (SDM) and trust building through continuity of care are known to play a pivotal role in improving appropriate antibiotic prescribing and use. Problem: However, less is known about how to effectively leverage these factors when present-or overcome them when not-to address community needs and improve patient liaison.Entities:
Keywords: antimicrobial resistance; community values; continuity of care; public engagement; shared decision-making; trusting relationships
Mesh:
Substances:
Year: 2022 PMID: 36249259 PMCID: PMC9561345 DOI: 10.3389/fpubh.2022.1001282
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Proportion of correct responses from 2004 Singapore residents on statements pertaining to antibiotic use and antimicrobial resistance (AMR), surveyed between November 2020 and January 2021. (A) Knowledge of statements related to understanding how antibiotics work. (B) Knowledge of statements related to antimicrobial resistance (AMR). (C) Knowledge related to appropriate ways of obtaining and taking antibiotics. (D) Understanding differences in correct response in (A–C), stratified by age (only significant trends reported).
Gaps in knowledge, themes collated from focus group discussion data.
|
|
|
|
|---|---|---|
| Specific gaps in the community's knowledge around reasons to take and minimize antibiotic use where appropriate | • Inability to differentiate between bacteria and viruses | “Antibiotics [are] for virus…if you're not in a medical line, you [will] get confused with bacteria, virus, germs…but I know that antibiotics are for viruses.” |
| • Misconception that an antibiotic is the same as a painkiller, or an anti-inflammatory agent | “They said it was to reduce inflammation…Ya, for disinfection…Only take it when the illness is severe.” | |
| • Overuse of antibiotics was seen as leading to the “body building immunity” against the antibiotics, not the bacteria itself becoming resistant | “If doctor gives you medications, once you are well…once you are healed, stop. If not, the next time you are sick…It's like body has become used to it…the immunity toward antibiotics is inside of us…our protection is no longer there. So even if we eat antibiotic, it would no longer be effective.” | |
| Poor understanding of AMR | • Lay beliefs rather than scientific consensus were commonly being used to define the term “antibiotic resistance” | “Is it something where your body doesn't work on the antibiotics, already reached its maximum potency, like a dependency…It's like reached its limit…won't work for you anymore, is that it?” |
| • Misconception that effects of antibiotic resistance are cumulative by age | “So we are the pioneer. We eat more, we take more of this [referring to antibiotics]. When it comes to resistance…it is possible that is not very effective to the elderly. Because we already built up something inside [our body] already.” |
Univariate and multivariable logistic regression examining factors associated with preference for shared decision-making on antibiotic prescribing, N = 2004.
|
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||||
| Yes | 22 (8) | 227 (13) |
| 1.79 | 1.13–2.81 |
| 1.75 | 1.10–2.77 |
| 1.75 | 1.10–2.77 |
|
| Yes | 156 (56) | 1,077 (62) |
| 1.32 | 1.03–1.71 |
| 1.27 | 0.98–1.65 | 0.075 | 0.93 | 0.60–1.45 | 0.746 |
| Male | 132 (47) | 822 (48) | 0.867 | 1.02 | 0.79–1.32 | 0.867 | 1.02 | 0.79–1.32 | 0.860 | 1.02 | 0.79–1.31 | 0.907 |
| 21–34 years old | 94 (34) | 521 (30) | 0.507 | Ref | – | – | Ref | – | – | Ref | – | – |
| 35–49 years old | 90 (32) | 568 (33) | 1.14 | 0.83–1.56 | 0.415 | 1.18 | 0.86–1.62 | 0.317 | 1.05 | 0.65–1.67 | 0.852 | |
| ≥50 years old | 96 (34) | 635 (37) | 1.19 | 0.88–1.62 | 0.259 | 1.37 | 0.97–1.93 | 0.075 | 0.94 | 0.58–1.52 | 0.796 | |
|
| ||||||||||||
| Non-Chinese | 61 (22) | 505 (29) |
| 1.49 | 1.10–2.01 |
| 1.59 | 1.17–2.17 |
| 1.60 | 1.18–2.19 |
|
|
| ||||||||||||
| Lower educated (Post-secondary & below) | 105 (37) | 591 (34) | 0.294 | Ref | – | – | Ref | – | – | Ref | – | – |
| Higher educated (Diploma & above) | 175 (63) | 1,133 (66) | 1.15 | 0.89–1.49 | 0.294 | 1.36 | 1.01–1.82 |
| 1.38 | 1.03–1.85 |
| |
| No | 188 (67) | 1,168 (68) | 0.840 | 1.03 | 0.79–1.35 | 0.840 | – | – | – | – | – | – |
| Yes | 133 (47) | 943 (55) |
| 1.33 | 1.04–1.72 |
| – | – | – | – | – | – |
| Product term | – | – | – | – | – | – | – | – | – | 1.29 | 0.68–2.44 | 0.425 |
| Product term | – | – | – | – | – | – | – | – | – | 1.97 | 1.05–3.67 |
|
Bolded values indicate statistical significance of P < 0.05.
Intentions and behavioral follow-through, themes collated from focus group discussion data.
|
|
|
|
|---|---|---|
| While the best ways to obtain antibiotics and the advice on taking them was generally known, this did not always translate to good practices | • The misconception that the body, not the bacteria, became resistant was one reason why the full dose of prescribed antibiotics might not be completed | “I try not to finish in a way I got my body to be used to it [referring to antibiotics].” |
| • Requesting tried-and-tested antibiotics was driven by the desire to recover from an illness faster | “Because I wanted to recover faster. I had some event [going] on, so I requested them because antibiotics normally works much faster. So I did request.” |
Figure 2Proportion of responses from 2004 Singapore residents, surveyed between November 2020 and January 2021, agreeing to these statements pertaining to trust in doctors, continuity of care and shared decision-making (SDM) for antibiotic prescribing, stratified by age.
Association between preference for shared decision-making on antibiotic prescribing and continuity of care, according to age group, N = 2004.
|
| ≥ | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| Lacks continuity of care | Ref | – | Ref | – | 0.374 | Ref | – |
|
| With continuity of care | 0.98 | 0.63–1.53 | 1.23 | 0.78–1.93 | 1.83 | 1.18–2.85 | ||
|
| ||||||||
| Lacks continuity of care | Ref | – | Ref | – | 0.425 | Ref | – |
|
| With continuity of care | 0.93 | 0.60–1.45 | 1.20 | 0.76–1.89 | 1.83 | 1.18–2.86 | ||
Multiplicative scale.
Adjusted for trust in doctor, gender, ethnic group, and highest educational level.
Bolded values indicate statistical significance of P < 0.05.
Figure 3Proportion of trust on different health information sources of 2004 Singapore residents surveyed between November 2020 and January 2021, stratified by age. The * was used to denote categories with statistical significance.
Trust building, themes collated from focus group discussion data.
|
|
|
|
|---|---|---|
| Value-add through taking time to build trust | • In some cases, trust was not a given | “Too much false information out there. People no longer trust already. Even doctors, not a lot of people trust [them]a” |
| • Trust can be built by better communication and sharing of knowledge | “Because the doctor also did not inform us of anything. “You just eat this medication” like this…or breakdown what will happen…the doctor didn't let us know. Just asked us to finish eating this [referring to antibiotics], that's all we know.” | |
| Valuing of public education on appropriate antibiotic use and AMR | • Importance of twinning trusted role of doctor with outreach and scientific information | “For the general public, usually whatever instruction is given by the doctor, they [follow]. Because these are the doctor's instructions. But it's not being widely published in the newspapers, so we don't know enough [to understand why instructions are given as they are].” |
| • Observed lack of public outreach on AMR as compared to other chronic or lifestyle diseases, e.g., diabetes | “Most of the common people, the public, most of us, we are not alerted of this antibiotic resistance. We are not alerted, you see. So we don't know what [is the] cause, what is the outcome of it, the seriousness is that when you get antibiotic resistance.” |
Continuity of care, themes collated from focus group discussion data.
|
|
|
|
|---|---|---|
|
| • Returning for follow-up consultations was directly connected to valuing existing relationships | “I always go and see the same doctor. Never [do I] go to other clinics… [if] my condition still did not improve, he will give me antibiotics.” |
| • Also, enabled or hindered by practical factors, such as proximity, waiting times, speed and efficiency of diagnosis etc. | “You know, think about the doctors, the queues just put me off.” |
Shared decision-making, themes collated from focus group discussion data.
|
|
|
|
|---|---|---|
| Valuing of SDM on antibiotic prescribing | • Expressed by the desire to have healthcare professionals as main focal point of education | “If you do too much mass education…it's meaningless to me. I don't know what is antibiotic because I don't take antibiotic, right? Unless I am sick and I need to take antibiotic, and the person who prescribes it to me or at the pharmacy tells me “You must make sure you finish this for this reason.” That education will be very helpful. And maybe at the same time, give me a pamphlet. That way I will read and say, “Okay, I know why I need to complete.”” |
| • Initiation of SDM was not experienced as a “matter of course”—it may, or may not happen | “From my personal experience, the doctor has never discussed it [referring to antibiotic prescribing] with me. And I think I would prefer that…perhaps, more doctors could discuss it with the patients.” | |
| • Communication to redress the lack of SDM, for instance tackling poor knowledge and empowering patients, perceived as the doctor's responsibility | “From the point where the medicine is being prescribed…say “Okay, I'm going to give you this. Do you understand what you are taking? Do you understand the risk behind taking it, and properly taking it and what not properly taking it would do?” And then once you finish, sign it…you should make it mandatory for all GPs and healthcare providers.” |
Figure 4A strategic implementation model to guide the designing of interventions to improve appropriate antibiotic use in the general public.